142 related articles for article (PubMed ID: 35276347)
1. Activation of the unfolded protein response by Connexin47 mutations associated with Pelizaeus-Merzbacher-like disease.
Flores-Obando RE; Freidin MM; Hernández AI; Abrams CK
Mol Cell Neurosci; 2022 May; 120():103716. PubMed ID: 35276347
[TBL] [Abstract][Full Text] [Related]
2. Investigating oligodendrocyte connexins: Heteromeric interactions between Cx32 and mutant or wild-type forms of Cx47 do not contribute to or modulate gap junction function.
Abrams CK; Flores-Obando RE; Dungan GD; Cherepanova E; Freidin MM
Glia; 2021 Aug; 69(8):1882-1896. PubMed ID: 33835612
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations in the GJC2 gene associated with Pelizaeus-Merzbacher-like disease.
Owczarek-Lipska M; Mulahasanovic L; Obermaier CD; Hörtnagel K; Neubauer BA; Korenke GC; Biskup S; Neidhardt J
Mol Biol Rep; 2019 Aug; 46(4):4507-4516. PubMed ID: 31270756
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease.
Orthmann-Murphy JL; Enriquez AD; Abrams CK; Scherer SS
Mol Cell Neurosci; 2007 Apr; 34(4):629-41. PubMed ID: 17344063
[TBL] [Abstract][Full Text] [Related]
5. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans.
Tress O; Maglione M; Zlomuzica A; May D; Dicke N; Degen J; Dere E; Kettenmann H; Hartmann D; Willecke K
PLoS Genet; 2011 Jul; 7(7):e1002146. PubMed ID: 21750683
[TBL] [Abstract][Full Text] [Related]
6. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form.
Biancheri R; Rosano C; Denegri L; Lamantea E; Pinto F; Lanza F; Severino M; Filocamo M
Eur J Hum Genet; 2013 Jan; 21(1):34-9. PubMed ID: 22669416
[TBL] [Abstract][Full Text] [Related]
7. The distribution and functional properties of Pelizaeus-Merzbacher-like disease-linked Cx47 mutations on Cx47/Cx47 homotypic and Cx47/Cx43 heterotypic gap junctions.
Kim MS; Gloor GB; Bai D
Biochem J; 2013 Jun; 452(2):249-58. PubMed ID: 23544880
[TBL] [Abstract][Full Text] [Related]
8. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.
Orthmann-Murphy JL; Salsano E; Abrams CK; Bizzi A; Uziel G; Freidin MM; Lamantea E; Zeviani M; Scherer SS; Pareyson D
Brain; 2009 Feb; 132(Pt 2):426-38. PubMed ID: 19056803
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Diseases Associated with Mutation in GJC2/Connexin 47.
Abrams CK
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189458
[TBL] [Abstract][Full Text] [Related]
10. Diseases of connexins expressed in myelinating glia.
Abrams CK
Neurosci Lett; 2019 Mar; 695():91-99. PubMed ID: 28545922
[TBL] [Abstract][Full Text] [Related]
11. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
Hobson GM; Garbern JY
Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
[TBL] [Abstract][Full Text] [Related]
12. Changes in object recognition and anxiety-like behaviour in mice expressing a Cx47 mutation that causes Pelizaeus-Merzbacher-like disease.
Zlomuzica A; Tress O; Binder S; Rovira C; Willecke K; Dere E
Dev Neurosci; 2012; 34(2-3):277-87. PubMed ID: 22832166
[TBL] [Abstract][Full Text] [Related]
13. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
[TBL] [Abstract][Full Text] [Related]
14. Different Mutations of Gap Junction Connexin 47 Lead to Discrepant Activation of Unfolded Protein Response Pathway in Pelizaeus-Merzbacher-Like Disease.
Chen N; Wang J; Jiang Y; Wu Y; Hao H; Ji T
Neuropediatrics; 2017 Dec; 48(6):426-431. PubMed ID: 28712094
[No Abstract] [Full Text] [Related]
15. Transgenic replacement of Cx32 in gap junction-deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Schiza N; Sargiannidou I; Kagiava A; Karaiskos C; Nearchou M; Kleopa KA
Hum Mol Genet; 2015 Apr; 24(7):2049-64. PubMed ID: 25524707
[TBL] [Abstract][Full Text] [Related]
16. Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene.
Sartori S; Burlina AB; Salviati L; Trevisson E; Toldo I; Laverda AM; Burlina AP
Eur J Paediatr Neurol; 2008 Jul; 12(4):348-50. PubMed ID: 17881259
[TBL] [Abstract][Full Text] [Related]
17. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease.
Osaka H; Hamanoue H; Yamamoto R; Nezu A; Sasaki M; Saitsu H; Kurosawa K; Shimbo H; Matsumoto N; Inoue K
Ann Neurol; 2010 Aug; 68(2):250-4. PubMed ID: 20695017
[TBL] [Abstract][Full Text] [Related]
18. Pelizaeus-Merzbacher-Like Disease 1 Caused by a Novel Mutation in GJC2 Gene: A Case Report.
Javadikooshesh S; Zaimkohan H; Pourghorban P; Bahramim F; Ebadi N
Iran J Med Sci; 2021 Nov; 46(6):493-497. PubMed ID: 34840390
[TBL] [Abstract][Full Text] [Related]
19. Gap junction disorders of myelinating cells.
Kleopa KA; Orthmann-Murphy J; Sargiannidou I
Rev Neurosci; 2010; 21(5):397-419. PubMed ID: 21280457
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of gap junction mutations in myelinating cells.
Sargiannidou I; Markoullis K; Kleopa KA
Histol Histopathol; 2010 Sep; 25(9):1191-206. PubMed ID: 20607661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
